focus -WSS

focus

author：focus 2025-10-04 04:01:12 - browse：24194

UnitedHealth's CEO Andrew Witty stares into the camera at a hearing with his fingers locked — politics coverage from STAT — Kent Nishimura/Getty Images

On Wednesday, UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a “single attack [that] kicked off a cascading series of crises that are unmasking some deep vulnerabilities in the core of our health care system”: the February Change Healthcare cyberattack that is still disrupting payment processing across the country.

Senators repeatedly interrupted Witty, trying to keep him to concrete answers and promises. Lawmakers on both sides of the aisle were exasperated with UnitedHealth. At one point, Sen. Thom Tillis (R-N.C.) held up a fifth-edition copy of “Hacking for Dummies” during the hearing.

“This is some basic stuff that was missed,” he said, referring to the fact that the hackers gained access to a Change server that didn’t have multi-factor authentication, a big problem for a company whose business is digital data. “So shame on internal audit, external audit and your system folks, those tasked with redundancy, they’re not doing their job. And as a result, we have a data breach.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Readout LOUD podcast: mifepristone case, GLP

WSS

FDA's naming rule on biosimilars has undermined competition

Vertex Pharmaceuticals may move headquarters in Boston

Patient advocates debate FDA's accelerated approval process

Scientists boost immune system in aging mice by making it youthful

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Trump's false claims about Georgia's 2020 election long debunked

entertainment

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Lung cancer is America's deadliest cancer. Yet so few get screened

Activists slam private health insurers over coverage restrictions

Merck drug for rare lung condition set for approval in U.S.

After affirmative action ruling, medical educators look to 'holistic review'

Abortion pill Supreme Court ruling could impact entire drug industry

At least 13 dead in Texas as scorching temps continue

The pain doctors face in trying to build their families

New air purifier tech could be key to improving indoor air quality

Beware the threat of staffing cuts at the CDC

hotspot

Lung cancer is America's deadliest cancer. Yet so few get screened

Evacuations in place as 3 wildfires burn in eastern Washington state

ActiGraph execs on goal of drug approvals with digital endpoints

Abortion pill Supreme Court ruling could impact entire drug industry

FDA's naming rule on biosimilars has undermined competition

Hilary may become 1st tropical storm to make landfall in California in 84 years

knowledge

hotspot

Wikipedia

hotspot